Globe Newswire

EQUINIX, INC. (NASDAQ: EQIX) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Equinix, Inc. May 3, 2024 11:15AM

NEW YORK, May 03, 2024 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP:

• Do you, or did you, own shares of Equinix, Inc. (NASDAQ: EQIX)?
• Did you purchase your shares between May 3, 2019 and March 24, 2024, inclusive?
• Did you lose money in your investment in Equinix, Inc.?
• Do you want to discuss your rights?

Bernstein Liebhard LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or acquired the securities of Equinix, Inc.... (continue reading...)

EIB submits Annual Financial Report 2023 on Form 18-K May 3, 2024 11:12AM

3 May 2024

The EIB submits SEC Form 18-K

The European Investment Bank (EIB) has submitted its SEC Form 18-K.

To view the document, please go to: EDGAR Filing Documents for 0001104659-24-056727 (sec.gov).

The 18-K has also been posted on the EIB website:

EIB annual 18-K report 2023

ENDS

HighCo: Shareholding as 04/30/2024 May 3, 2024 11:10AM

INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES

Declaration pursuant to Articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulations of the Autorité des marchés financiers (AMF)

Date of settlementof informationTotal number of sharesNumber of shares without voting rights (*)Number of voting rights for threshold calculation (**)Number of actual voting rights (exercisable at shareholders’ meeting)April 30,... (continue reading...)

TDS Telecom hits expansion market milestone, reports strong financial results May 3, 2024 11:05AM

Madison, Wisconsin, May 03, 2024 (GLOBE NEWSWIRE) -- TDS Telecommunications LLC (TDS®) shared several positive developments in its first quarter earnings report. The Madison, Wisconsin-based telecommunications company delivered its strongest quarter of revenues since commencing its fiber expansion program with a 5% increase in total operating revenues, along with an increase in profitability in the quarter. The company also reached a major milestone: exceeding... (continue reading...)

PharmAla Launches Prescriber’s Portal for Medical Professionals Focused on MDMA Therapy May 3, 2024 11:00AM

TORONTO, May 03, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class molecules), is pleased to announce that it has officially launched its Prescribers Portal for medical practitioners with prescribing power to learn more about MDMA, its effects, and the potential... (continue reading...)